ZYGFLOVI
Live / Applied — First extension granted (statement of use) (as of 16 Apr 2025)
What this means for you
Not registered yet, but its 16 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98359121
- Mark type
- Stylized text
- Filed
- 16 Jan 2024
- Published for opposition
- 17 Sept 2024
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations based upon human allogeneic bone marrow mesenchymal stem cell derived extracellular vesicles (EVs) containing secretomes for the treatment of immunomodulatory, inflammatory, or autoimmune conditions such as respiratory diseases, neurological diseases, tissue injury and repair, gastrointestinal diseases, joint diseases and transplant.
Owner
- Direct Biologics LLC, Austin, TX, US
- Direct Biologics LLC, Austin, TX, US
Prosecution history
- 31 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Jun 2025 — ASSIGNED TO EXAMINER
- 17 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Apr 2025 — SOU EXTENSION 1 GRANTED
- 16 Apr 2025 — SOU EXTENSION 1 FILED
- 16 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Sept 2024 — PUBLISHED FOR OPPOSITION
- 28 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Aug 2024 — ASSIGNED TO EXAMINER
- 10 Jul 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Jul 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 10 Jul 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED